ALEXANDRIA, Va., Feb. 12 -- United States Patent no. 12,221,434, issued on Feb. 11, was assigned to INFLAZOME Ltd. (Dublin).
"Sulfonamide carboxamide compounds" was invented by Matthew Cooper (Cambridge, Great Britain), David Miller (Cambridge, Great Britain), Angus Macleod (Cambridge, Great Britain), Stephen Thom (Nottingham, Great Britain), Jonathan Shannon (Nottingham, Great Britain) and Jokin Carrillo Arregui (Nottingham, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to sulfonylureas and sulfonylthioureas comprising a 5-membered heteroaryl group substituted with a monovalent heteroaryl-containing group. The present invention further relates to salts, solvates ...